Loading...

MedXY News - ophthalmology

MedXY AI/MedXY News/Tag: ophthalmology

MedXY News

EnglishTag

ophthalmology

28 all articles · 20 / page

Ask MedXY AI

type 2 diabetes clinical trial immunotherapy heart failure obesity atrial fibrillation cardiovascular risk Cardiology biomarkers clinical trials Hypertension oncology public health critical care artificial intelligence breast cancer Alzheimer's disease diabetes cardiovascular disease type 1 diabetes nutrition chronic kidney disease

Latest news

Tag

Increased Risk of Dry Eye Disease in Patients with Chronic Pain Conditions: Insights from a Large Retrospective Cohort Study

Increased Risk of Dry Eye Disease in Patients with Chronic Pain Conditions: Insights from a Large Retrospective Cohort Study

Chronic pain conditions significantly elevate the risk of developing dry eye disease, including cases requiring prescription therapy, emphasizing the need for integrated clinical assessment and management.

Section: newsJul 20, 2026

Bridging the Gap: Geographic Disparities in Access to Diabetic Retinopathy Care Across the United States

Bridging the Gap: Geographic Disparities in Access to Diabetic Retinopathy Care Across the United States

This study reveals significant urban-rural disparities in access to diabetic retinopathy diagnostic and therapeutic services in the U.S., underscoring the need for targeted strategies to improve care in non-urban areas.

Section: Diabetes & EndocrinologyJul 17, 2026

Artificial Intelligence Smart Eyeglasses for the Detection and Description of Stationary Objects: A Pilot Feasibility Study

Artificial Intelligence Smart Eyeglasses for the Detection and Description of Stationary Objects: A Pilot Feasibility Study

A pilot study evaluating Ray-Ban Meta AI eyeglasses demonstrated high accuracy in single object identification and moderate performance in descriptive tasks, suggesting promise for aiding individuals with low vision.

Section: AIJul 15, 2026

A Consensus Reference Standard for AI Screening of Age-Related Macular Degeneration: What Clinicians and Developers Need to Know

A Consensus Reference Standard for AI Screening of Age-Related Macular Degeneration: What Clinicians and Developers Need to Know

A 2026 expert consensus defines an image-based reference standard to validate AI screening algorithms for age-related macular degeneration (AMD), endorsing Beckman grading and routine OCT use while clarifying referral thresholds and areas o

Section: AIJul 15, 2026

Blood Pressure Assessment in Ophthalmology Clinics for Patients With Diabetes: A Case Series Analysis

Blood Pressure Assessment in Ophthalmology Clinics for Patients With Diabetes: A Case Series Analysis

This case series reveals a high prevalence of uncontrolled hypertension among diabetic patients visiting ophthalmology clinics and highlights the importance of in-clinic blood pressure screening to identify and manage cardiovascular risk.

Section: Diabetes & EndocrinologyJul 9, 2026

Disparities in Access to Intravitreal Anti-VEGF Therapies Among Medicare Advantage Versus Fee-for-Service Beneficiaries

Disparities in Access to Intravitreal Anti-VEGF Therapies Among Medicare Advantage Versus Fee-for-Service Beneficiaries

Medicare Advantage beneficiaries receive fewer higher-cost anti-VEGF injections compared to Fee-for-Service patients, highlighting potential access disparities to newer ophthalmic therapies.

Section: newsJul 6, 2026

Long-Term Assessment of Rose Bengal Photodynamic Therapy in Infectious Keratitis: Insights from the REAGIR Randomized Trial

Long-Term Assessment of Rose Bengal Photodynamic Therapy in Infectious Keratitis: Insights from the REAGIR Randomized Trial

A 12-month follow-up of the REAGIR trial found no significant benefit of adjunctive rose bengal photodynamic therapy with green light over sham treatment in improving visual acuity, scar size, or complication rates in infectious keratitis.

Section: Infectious DiseasesJun 29, 2026

Semaglutide and Neovascular Age-Related Macular Degeneration Among Adults with Type 2 Diabetes: An OHDSI Network Study

Semaglutide and Neovascular Age-Related Macular Degeneration Among Adults with Type 2 Diabetes: An OHDSI Network Study

In a large OHDSI network study of adults with type 2 diabetes, semaglutide was not associated with a higher or lower risk of neovascular age-related macular degeneration.

Section: Diabetes & EndocrinologyJun 10, 2026

Immune Checkpoint Inhibitor-Associated Uveitis: Comparative Risk Across Cancers and Drug Classes

Immune Checkpoint Inhibitor-Associated Uveitis: Comparative Risk Across Cancers and Drug Classes

A multicenter study found that immune checkpoint inhibitor–associated uveitis risk varies by cancer type and drug class, with melanoma showing the highest intrinsic risk and RCC risk largely linked to ipilimumab/nivolumab exposure.

Section: newsJun 4, 2026

Anesthesia-Related Neurologic Risk in Patients of Venezuelan Descent: Implications for Ophthalmology

Anesthesia-Related Neurologic Risk in Patients of Venezuelan Descent: Implications for Ophthalmology

A rare, severe neurologic complication has been linked to general anesthesia in patients of maternal Venezuelan descent. Ophthalmologists should screen for ancestry and family history, involve anesthesiology early, and consider genetic eval

Section: AnesthesiologyMay 21, 2026

Optimizing Geographic Atrophy Clinical Trial Design: The Role of Run-In Phases, Single-Arm Architectures, and Functional Endpoints

Optimizing Geographic Atrophy Clinical Trial Design: The Role of Run-In Phases, Single-Arm Architectures, and Functional Endpoints

This review synthesizes evidence on improving geographic atrophy trial efficiency through innovative run-in phases, single-arm designs, and superior functional biomarkers like microperimetry to reduce required sample sizes.

Section: Clinical UpdatesMay 20, 2026

GLP-1 Weight-Loss and Diabetes Drugs: What Eye Specialists Say About NAION Risk

GLP-1 Weight-Loss and Diabetes Drugs: What Eye Specialists Say About NAION Risk

A new consensus statement advises cautious, shared decision-making about GLP-1 receptor agonists and NAION risk, noting that current evidence is observational, conflicting, and suggests any absolute risk increase is small.

Section: newsMay 18, 2026

Seeing the Invisible: New Global Consensus on Using Advanced Imaging to Track Uveitis Activity

Seeing the Invisible: New Global Consensus on Using Advanced Imaging to Track Uveitis Activity

A global task force has established new standardized imaging measures to define disease activity in non-infectious posterior uveitis, bridging a critical gap in clinical diagnosis and trial monitoring.

Section: newsMar 24, 2026

$LISA MRS Formula Outperforms Existing Standards for IOL Calculation in Post-Refractive Surgery Patients, Especially in High Myopia$

LISA MRS Formula Outperforms Existing Standards for IOL Calculation in Post-Refractive Surgery Patients, Especially in High Myopia

A new IOL power calculation formula, LISA MRS, demonstrates superior accuracy for cataract patients with prior myopic refractive surgery, significantly outperforming existing formulas in eyes with axial lengths of 28 mm or greater by utiliz

Section: newsMar 19, 2026

The Persistence of Ophthalmic Scarcity: A 23-Year Longitudinal Analysis of Drug Shortages in the United States

The Persistence of Ophthalmic Scarcity: A 23-Year Longitudinal Analysis of Drug Shortages in the United States

This review analyzes ophthalmic drug shortages from 2001 to 2024, revealing that eye medications face longer shortage durations than other drug classes, significantly influenced by patent status and manufacturing transparency.

Section: Clinical UpdatesMar 21, 2026

Impact of Long-Term Intravitreal Anti-VEGF Injections on Cataract Progression and Surgical Outcomes

Impact of Long-Term Intravitreal Anti-VEGF Injections on Cataract Progression and Surgical Outcomes

A longitudinal study of 603 patients demonstrates that chronic intravitreal anti-VEGF therapy significantly accelerates cataract development, particularly posterior subcapsular opacities, resulting in an eightfold increased risk for catarac

Section: newsMar 16, 2026

High-Frequency TENS Shows Promise for Nociplastic Ocular Pain in Randomized Pilot Trial

High-Frequency TENS Shows Promise for Nociplastic Ocular Pain in Randomized Pilot Trial

This randomized pilot study demonstrates that high-frequency TENS significantly improves specific neuropathic ocular pain symptoms over three months, offering a non-invasive, non-pharmacological alternative for patients with refractory ocul

Section: NeurologyMar 13, 2026

Beyond the Cornea: Evaluating the Systemic Cardiometabolic Burden in Fuchs’ Endothelial Corneal Dystrophy

Beyond the Cornea: Evaluating the Systemic Cardiometabolic Burden in Fuchs’ Endothelial Corneal Dystrophy

Recent data from the NIH All of Us Research Program indicates that Fuchs’ Endothelial Corneal Dystrophy (FECD) is associated with a significantly higher prevalence of cardiometabolic comorbidities, suggesting a systemic component to this tr

Section: Clinical UpdatesMar 13, 2026

Optimizing Glaucoma Management through Behavioral Intervention: Insights from the SEE Randomized Clinical Trial

Optimizing Glaucoma Management through Behavioral Intervention: Insights from the SEE Randomized Clinical Trial

The SEE randomized clinical trial demonstrates that a 6-month personalized coaching program using motivational interviewing significantly improves glaucoma medication adherence and reduces patient distress compared to standard education.

Section: Clinical UpdatesMar 2, 2026

Human-AI Collaboration Enhances Clinical Reasoning in Ophthalmology but Risks Overconfidence and Automation Bias

Human-AI Collaboration Enhances Clinical Reasoning in Ophthalmology but Risks Overconfidence and Automation Bias

A crossover study involving 30 ophthalmologists and trainees reveals that while Claude-3.5-Sonnet collaboration improves diagnostic accuracy in complex cases, it also increases confidence in incorrect decisions and fails to reach the perfor

Section: AIFeb 22, 2026